Target intelligence / Profile preview

Ribosomal protein S12 pseudogene 32 (RPS12P32)

Target
RPS12P32
Molecular classification
Other, Processed pseudogene
01

Overview

Ribosomal protein S12 pseudogene 32 (RPS12P32) is a processed pseudogene derived from the ribosomal protein S12 gene family. Pseudogenes are segments of DNA that resemble known genes but are generally nonfunctional due to mutations or lack of regulatory elements necessary for expression[6]. RPS12P32 does not code for a functional protein, is not known to play a direct biological or pathological role, and is not utilized as a therapeutic or diagnostic target in medicine. The protein-coding version, ribosomal protein S12, is a component of the small (40S) ribosomal subunit, but the "pseudogene 32" specifically denotes a non-coding, non-functional genomic remnant[3][6]. Additional context: - Pseudogenes are common for ribosomal protein families, arising via gene duplication or retrotransposition followed by loss of function; many exist for RPS12 throughout the genome[1][3]. - RPS12P32 lacks evidence for encoding any significant domain or functional peptide, as is standard for most pseudogenes[6]. - Listings in research databases (e.g., Merck Millipore) are for cataloguing purposes, not for functional annotation or therapeutic relevance[2]. - No drugs, diseases, or diagnostic markers are associated with this pseudogene, and it is not classified as a signaling receptor, enzyme, transporter, or other canonical drug target class. Summary: Ribosomal protein S12 pseudogene 32 is a non-functional pseudogene, not a protein or therapeutic target, and is thus considered incorrect/redundant as a biomedical target entry.

Beyond the preview

Go deeper on Ribosomal protein S12 pseudogene 32 (RPS12P32).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein S12 pseudogene 32 (RPS12P32).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call